Blood glucose regulation is often presented as a direct cause-and-effect relationship between carbohydrate intake and circulating glucose levels. However, this framework is incomplete. The human body has multiple endogenous mechanisms that raise blood glucose independently of dietary carbohydrate, and these mechanisms can become more pronounced as insulin sensitivity declines. For individuals monitoring glucose patterns, understanding these physiological pathways is essential for interpreting unexpected trends.
This article outlines the primary biological processes that elevate glucose without carbohydrate ingestion and explains how these responses relate to early metabolic dysfunction.
Hepatic Glucose Output: Glycogenolysis and Gluconeogenesis
The hepatic glucose output via the liver plays a central role in maintaining plasma glucose within a narrow range, even during periods of low carbohydrate availability. It does this through two pathways:
Glycogenolysis involves the breakdown of hepatic glycogen stores into glucose, which is then released into circulation.
Gluconeogenesis synthesizes new glucose molecules primarily from amino acids, lactate, and glycerol.
Both processes are normal and continuous. However, in states of insulin resistance, hepatic insulin signaling becomes impaired. When insulin cannot effectively suppress hepatic glucose production, the liver produces and releases glucose at a rate disproportionate to physiological need. This excessive hepatic output can result in elevated fasting or post-absorptive glucose levels, even when dietary carbohydrate is minimal or absent.
The Counterregulatory Hormone Response
Blood glucose is also influenced by the endocrine response to stress. Cortisol, epinephrine, norepinephrine, and glucagon all stimulate hepatic glucose release. These hormones increase during psychological stress, insufficient sleep, acute illness, pain, and high-intensity physical activity. Their role is adaptive: to ensure glucose availability during perceived threat or increased energy demand.
In individuals with reduced insulin sensitivity, the glucose-raising impact of these hormones is less effectively counterbalanced by insulin, allowing glucose levels to rise more and remain elevated longer.
Dawn Phenomenon and Circadian Hormonal Shifts
Early-morning glucose elevation is a well-documented phenomenon driven by circadian increases in growth hormone, cortisol, and catecholamines. These hormones promote hepatic glucose release and reduce peripheral glucose uptake for several hours after waking.
Individuals with insulin resistance tend to exhibit a heightened or prolonged dawn response. Even with no morning food intake, glucose may rise or remain elevated due to this predictable hormonal pattern.
Metabolic Flexibility, Fat Oxidation, and the Randle Cycle
The capacity to switch efficiently between glucose and fat as fuel (known as metabolic flexibility) is impaired early in insulin resistance. The Randle Cycle provides a framework for understanding this: when fatty acid oxidation is dominant, glucose oxidation is downregulated. In individuals with reduced insulin sensitivity, this shift can make glucose disposal less efficient, so glucose derived from endogenous sources may be cleared more slowly.
This mechanism provides one plausible explanation for why some people following low-carbohydrate diets observe larger-than-expected glucose excursions from small glucose inputs.
Ingredient Factors and Hidden Carbohydrates
Although less physiologically significant than the pathways above, it is still possible for glucose to rise due to small amounts of carbohydrates in sauces, seasonings, dairy products, sugar alcohols, and processed foods. While this does occur, it is not the primary explanation for most unexplained glucose elevations in individuals with early insulin resistance.
Physiological Glucose Variability
It is important to note that not all glucose elevations reflect dysfunction. Glucose naturally fluctuates in response to circadian rhythm, physical activity, hormonal patterns, fasting, and the thermic effect of food. A rise is not inherently pathological; the pattern, magnitude, and rate of return to baseline are more informative indicators of metabolic status.
Interpreting These Patterns
When glucose rises in the absence of dietary carbohydrate, it typically reflects the interaction between hepatic glucose regulation, hormonal signaling, metabolic flexibility, and insulin sensitivity. These elevations do not diagnose insulin resistance, but they can serve as relevant early markers that the body is compensating for diminished metabolic efficiency long before conventional laboratory markers detect abnormalities.
Understanding these mechanisms allows individuals to interpret glucose trends more accurately and recognize patterns that merit further attention, lifestyle intervention, or clinical monitoring.
Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. The content of this article, provided by Insulin Resistance Lab, is for informational purposes only and does not constitute medical advice. It is not a substitute for professional advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about medical conditions, dietary changes, or lifestyle modifications. The information provided is intended for a general audience and may not apply to individual circumstances. Do not delay or disregard medical advice based on the content of this website. Insulin Resistance Lab (Holistic Fit LLC) assumes no responsibility for errors, omissions, or outcomes resulting from the use of this information. This content is provided “as is” without guarantees of completeness, accuracy, or timeliness. The author is not a licensed medical professional. References to specific products, research, or external websites are for informational purposes only and do not constitute endorsements or recommendations. Individual results may vary. Readers are encouraged to consult updated sources and verify information as scientific knowledge evolves.
References:
Barroso, E., Jurado-Aguilar, J., Wahli, W., Palomer, X., & Vázquez-Carrera, M. (2024). Increased hepatic gluconeogenesis and type 2 diabetes mellitus. Trends in Endocrinology and Metabolism: TEM, 35(12), 1062–1077. https://doi.org/10.1016/j.tem.2024.05.006
Chu, B., Marwaha, K., Sanvictores, T., Awosika, A. O., & Ayers, D. (2024). Physiology, stress reaction. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK541120/
Han, H. S., Kang, G., Kim, J. S., Choi, B. H., & Koo, S. H. (2016). Regulation of glucose metabolism from a liver-centric perspective. Experimental & Molecular Medicine, 48(3), e218. https://doi.org/10.1038/emm.2015.122
Hue, L., & Taegtmeyer, H. (2009). The Randle cycle revisited: a new head for an old hat. American journal of physiology. Endocrinology and Metabolism, 297(3), E578–E591. https://doi.org/10.1152/ajpendo.00093.2009
Mayo Clinic. (2022, November 12). The dawn phenomenon: What can you do? Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/diabetes/expert-answers/dawn-effect/faq-20057937
Poggiogalle, E., Jamshed, H., & Peterson, C. M. (2018). Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism: Clinical and Experimental, 84, 11–27. https://doi.org/10.1016/j.metabol.2017.11.017
Sharabi, K., Tavares, C. D., Rines, A. K., & Puigserver, P. (2015). Molecular pathophysiology of hepatic glucose production. Molecular Aspects of Medicine, 46, 21–33. https://doi.org/10.1016/j.mam.2015.09.003
Thorens B. (2022). Neuronal regulation of glucagon secretion and gluconeogenesis. Journal of Diabetes Investigation, 13(4), 599–607. https://doi.org/10.1111/jdi.13745
Wang, J. S., Lee, I. T., Lee, W. J., Lin, S. D., Su, S. L., Tu, S. T., Lin, S. Y., & Sheu, W. H. (2021). The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs. Therapeutic Advances in Chronic Disease, 12, 20406223211033674. https://doi.org/10.1177/20406223211033674